Heparinized polyurethanes: in vitro and in vivo studies.
Heparin immobilization chemistry using alkyl spacer arms was adapted to optimize yield on polyurethane (PU) surfaces. The resultant biological activity of immobilized heparin (HI) was examined in vitro and in vivo, and compared with a heparin releasing (HR) system. Immobilized heparin retained its ability to bind and inactivate thrombin and Factor Xa; nonspecific coagulation factor binding was insignificant. Such activity cannot be attributed to the leakage of improperly bound heparin. Immobilized heparin-polyurethane catheters implanted in canine femoral and jugular veins for 1 h periods exhibited significant reduction in thrombus formation compared with untreated PU contralateral controls. Polyurethane catheters coated with a 9% heparin dispersion in PU (HR) system provided even greater improvement in antithrombogenicity.
D000818:Animals; D001780:Blood Coagulation Tests; D002408:Catheters, Indwelling / Q000009:adverse effects; D004285:Dogs; D005170:Factor X / Q000378:metabolism*; D015951:Factor Xa; D005260:Female; D006400:Hematocrit; D006493:Heparin; D008297:Male; D010314:Partial Thromboplastin Time; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count; D011140:Polyurethanes; D012501:Saphenous Vein / Q000187:drug effects / Q000473:pathology; D012756:Sheep; D013917:Thrombin / Q000378:metabolism*; D013918:Thrombin Time; D013927:Thrombosis / Q000139:chemically induced
D011140:Polyurethanes; D005170:Factor X; D006493:Heparin; D013917:Thrombin; D015951:Factor Xa